111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Update

111, Inc. Sponsored ADR (NASDAQ:YIGet Free Report) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 35,430 shares, an increase of 2,235.5% from the December 31st total of 1,517 shares. Currently, 0.7% of the company’s stock are sold short. Based on an average daily trading volume, of 113,328 shares, the short-interest ratio is currently 0.3 days. Based on an average daily trading volume, of 113,328 shares, the short-interest ratio is currently 0.3 days. Currently, 0.7% of the company’s stock are sold short.

111 Stock Up 1.3%

NASDAQ YI opened at $5.32 on Thursday. 111 has a 52 week low of $2.48 and a 52 week high of $11.35. The company has a market capitalization of $45.96 million, a P/E ratio of -6.33 and a beta of 0.51. The stock’s 50-day moving average price is $3.83 and its 200-day moving average price is $5.01.

111 (NASDAQ:YIGet Free Report) last released its earnings results on Wednesday, December 17th. The company reported ($1.20) earnings per share (EPS) for the quarter. The company had revenue of $421.49 million for the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of 111 in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Get Our Latest Stock Report on YI

About 111

(Get Free Report)

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.

Further Reading

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.